Please ensure Javascript is enabled for purposes of website accessibility

Statewide medical group names new CFO

Rich MacClary has worked with public and private equity-backed companies


  • By
  • | 3:00 p.m. February 15, 2021
  • | 2 Free Articles Remaining!
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Florida Cancer Specialists & Research Institute recently named Rich MacClary CFO.

MacClary will oversee the company’s finance and accounting operations, business planning and investments and fiscal compliance policy and practices, according to a statement.

“Rich brings to FCS significant experience and a genuine affinity for health care,” FCS CEO Nathan Walcker says in the release. “He will enhance our capacity and effectiveness in delivering world-class cancer care across Florida and navigating the many opportunities and challenges ahead.”

MacClary has held leadership positions establishing strategic direction and driving financial growth for both public and private equity-backed companies, the release states. His healthcare experience spans multi-site services, information technology and electronic payments. Companies held senior financial leadership roles with include Alliance Oncology, Healthcare Holdings of America, Comdata Inc. and Emdeon Inc. (now Change Healthcare). A U.S. Navy veteran, he began his career as an officer on the staff of the U.S. Naval Nuclear Propulsion

“Rich joins us with significant leadership experience and finance expertise,” FCS President & Managing Physician Dr. Lucio Gordan says in the release. “He is an excellent addition to our executive team.”

Fort Myers-based FCS, with more than 230 physicians, 220 advanced practice registered nurses and physician assistants and some 100 locations statewide, is also now one of the biggest oncology practices in Florida. It did $2.1 billion in revenue and collections in 2017, the last year it publicly disclosed revenue.

 

 

 

Latest News